SCHEMBL32669749

SCHEMBL32669749

CN(Cc1cc(C#N)ccc1F)C(=O)/C(C#N)=C(\O)c1cc(OC(F)F)c(O)c([N+](=O)[O-])c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 8/20 0.47
COMT P21964 7/20 0.47
MAOA P21397 2/20 0.35
MAOB P27338 2/20 0.35
TTR P02766 2/20 0.33
SNCA P37840 1/20 0.32
THRB P10828 2/20 0.32
MEN1 O00255 2/20 0.31
LMNA P02545 2/20 0.31
CYP2C9 P11712 2/20 0.31
KMT2A Q03164 2/20 0.31
GPR35 Q9HC97 2/20 0.31
ABCC3 O15438 1/20 0.31
ABCC4 O15439 1/20 0.31
ABCB11 O95342 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GMNN O75496 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669991 0.91 FTO (0.48) FTOCOMTTTRTHRBMEN1
SCHEMBL32670154 0.91 FTO (0.49) FTOCOMTMAOAMAOBTTR
SCHEMBL32669786 0.88 FTO (0.61) FTOCOMTMAOAMAOBTTR
SCHEMBL32670050 0.87 FTO (0.47) FTOCOMTTTRMEN1LMNA
SCHEMBL32669879 0.85 FTO (0.49) FTOCOMTMAOAMAOBTTR
SCHEMBL32669578 0.85 FTO (0.48) FTOCOMTTTRMEN1KMT2A
SCHEMBL32670003 0.84 FTO (0.51) FTOCOMTMAOAMAOBTTR
SCHEMBL32669738 0.83 FTO (0.52) FTOCOMTTTRSNCAMEN1
SCHEMBL32669717 0.83 FTO (0.63) FTOCOMTMAOAMAOBTTR
SCHEMBL32669713 0.82 FTO (0.60) FTOCOMTMAOAMAOBTTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 FTO 1/4885COMT 52/4885MAOA 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.